dc.creatorBARROS, Solange Murta
dc.creatorCARVALHO, Jozelio Freire de
dc.date.accessioned2012-10-19T17:01:17Z
dc.date.accessioned2018-07-04T15:04:18Z
dc.date.available2012-10-19T17:01:17Z
dc.date.available2018-07-04T15:04:18Z
dc.date.created2012-10-19T17:01:17Z
dc.date.issued2011
dc.identifierACTA REUMATOLOGICA PORTUGUESA, v.36, n.1, p.65-68, 2011
dc.identifier0303-464X
dc.identifierhttp://producao.usp.br/handle/BDPI/21408
dc.identifierhttp://apps.isiknowledge.com/InboundService.do?Func=Frame&product=WOS&action=retrieve&SrcApp=EndNote&UT=000288828700011&Init=Yes&SrcAuth=ResearchSoft&mode=FullRecord
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1618183
dc.description.abstractRecently, reports have suggested grouping different autoimmune conditions that are triggered by external stimuli as a single syndrome called autoimmune/inflammatory syndrome induced by adjuvants (ASIA). This syndrome is characterized by the appearance of myalgia, myositis, muscle weakness, arthralgia, arthritis, chronic fatigue, sleep disturbances, cognitive impairment and memory loss, and the possible emergence of a demyelinating autoimmune disease caused by systemic exposure after vaccines and adjuvants. In the current study, the authors reported the first Brazilian case of a woman who developed ASIA, which was characterized by arthralgia, changes in inflammatory markers, and chronic fatigue, after the pandemic anti-influenza A/H1N1 vaccine without causing any other rheumatic disease, and it had a positive outcome.
dc.languageeng
dc.publisherMEDFARMA-EDICOES MEDICAS, LDA
dc.relationActa Reumatologica Portuguesa
dc.rightsCopyright MEDFARMA-EDICOES MEDICAS, LDA
dc.rightsrestrictedAccess
dc.subjectPandemic H1N1 Influenza
dc.subjectVaccination
dc.titleSHOENFELD`S SYNDROME AFTER PANDEMIC INFLUENZA A/H1N1 VACCINATION
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución